Sintilimab:

Ya-Lei Lye1, Bin Shan2, Chen-Hong Jia3

  • 1Department of Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.

Annals of dermatology
|October 19, 2023
PubMed
概括

作为一种免疫检查点抑制剂,辛提利马布可以在癌症患者中引起严重的皮肤反应,例如有毒表皮解. 及时检测和用葡萄糖皮质类固醇治疗对于管理这些不良事件至关重要.